Vertex Pharmaceuticals, Inc. (VRTX)
504.73
-2.01
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
505.10
+0.37
(+0.07%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap : 127.87B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 127.87B |
| October 01, 2026 | 128.38B |
| September 30, 2026 | 132.45B |
| September 29, 2026 | 133.45B |
| September 28, 2026 | 133.68B |
| September 25, 2026 | 133.31B |
| September 24, 2026 | 132.34B |
| September 23, 2026 | 130.81B |
| September 22, 2026 | 130.47B |
| September 21, 2026 | 129.39B |
| September 18, 2026 | 128.79B |
| September 17, 2026 | 130.81B |
| September 16, 2026 | 130.03B |
| September 15, 2026 | 130.38B |
| September 14, 2026 | 131.62B |
| September 11, 2026 | 130.59B |
| September 10, 2026 | 130.36B |
| September 09, 2026 | 132.02B |
| September 08, 2026 | 134.00B |
| September 04, 2026 | 138.36B |
| September 03, 2026 | 141.36B |
| September 02, 2026 | 141.05B |
| September 01, 2026 | 138.75B |
| August 31, 2026 | 137.95B |
| August 28, 2026 | 137.24B |
| Date | Value |
|---|---|
| August 27, 2026 | 138.72B |
| August 26, 2026 | 138.65B |
| August 25, 2026 | 140.06B |
| August 24, 2026 | 138.73B |
| August 21, 2026 | 138.85B |
| August 20, 2026 | 136.87B |
| August 19, 2026 | 139.86B |
| August 18, 2026 | 133.82B |
| August 17, 2026 | 130.61B |
| August 14, 2026 | 128.13B |
| August 13, 2026 | 130.84B |
| August 12, 2026 | 133.19B |
| August 11, 2026 | 134.19B |
| August 10, 2026 | 132.73B |
| August 07, 2026 | 125.68B |
| August 06, 2026 | 122.63B |
| August 05, 2026 | 122.83B |
| August 04, 2026 | 121.28B |
| August 03, 2026 | 119.26B |
| July 31, 2026 | 120.85B |
| July 30, 2026 | 122.01B |
| July 29, 2026 | 122.43B |
| July 28, 2026 | 124.64B |
| July 27, 2026 | 121.74B |
| July 24, 2026 | 121.33B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Gilead Sciences, Inc. | 179.62B |
| Sionna Therapeutics, Inc. | 221.76M |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
| Ionis Pharmaceuticals, Inc. | 7.212B |
Market Cap Related Metrics
| PE Ratio | 29.36 |
| PS Ratio | 10.19 |
| PEG Ratio | 1.285 |
| Price to Book Value | 6.315 |
| Price to Free Cash Flow | 34.08 |
| Price | 504.73 |
| Earnings Yield | 3.41% |
| PEGY Ratio | 1.285 |
| Operating PE Ratio | 25.76 |
| Normalized PE Ratio | 28.58 |